FDA clearance
Colin Kerr
Published: Thursday, February 1, 2018
Topcon Medical Systems has announced that its PASCAL Laser has received FDA clearance (K171488) to offer Pattern Scanning Laser Trabeculoplasty (PSLT) for the reduction of intraocular pressure (IOP) associated with glaucoma.
PSLT is an advanced tissue-sparing laser treatment for reducing intraocular pressure in open-angle glaucoma.
“The availability of PSLT, offers now a clinically-proven glaucoma treatment technology to ophthalmologists in the US,” said Robert Gibson, Vice President, Eye Care Global Marketing, Topcon Corporation.
"Globally, we’ve seen success with the Streamline PSLT application and believe glaucoma specialists and comprehensive ophthalmologists in the United States will find this technology a useful addition to their treatment armamentarium.” http://global.topcon.com
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.